G protein-coupled receptor deorphanizations

Annual Review of Pharmacology and Toxicology

Volumn 53, Issue , 2013, Pages 127-146

  Civelli, Olivier ^a   Reinscheid, Rainer K ^a   Zhang, Yan ^a   Wang, Zhiwei ^a   Fredriksson, Robert ^b   Schiöth, Helgi B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

lipid mediators; neuropeptides; orphan receptors; phylogeny; reverse pharmacology

Indexed keywords

2 OXOGLUTARIC ACID; G PROTEIN COUPLED RECEPTOR; GHRELIN; KISSPEPTIN; LIGAND; NEUROPEPTIDE; OREXIN; SUCCINIC ACID; URIDINE DIPHOSPHATE GLUCOSE;

DNA SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

ANIMALS; HUMANS; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84872243626     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev-pharmtox-010611-134548     Document Type: Review

References (114)

1. Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, et al. 1986. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 321:75-79
2. Dohlman HG, Caron MG, Lefkowitz RJ. 1987. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry 26:2657-64
3. Bockaert J, Pin JP. 1999. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18:1723-29
4. Angers S, Salahpour A, Bouvier M. 2002. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42:409-35
5. Pierce KL, Premont RT, Lefkowitz RJ. 2002. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3:639-50
6. Kristiansen K. 2004. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol. Ther. 103:21-80
7. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ. 2012. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu. Rev. Pharmacol. Toxicol. 52:179-97
8. Rask-Andersen M, Almen MS, Schi ̈ oth HB. 2011. Trends in the exploitation of novel drug targets. Nat. Rev. Drug Discov. 10:579-90
9. Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, et al. 1988. Cloning and expression of a ratD2 dopamine receptor cDNA. Nature 336:783-87
10. Libert F, Parmentier M, Lefort A, Dinsart C, Van Sande J, et al. 1989. Selective amplification and cloning of four members of the G protein-coupled receptor family. Science 244:569-72
11. Libert F, Schiffmann SN, Lefort A, Parmentier M, Gerard C, et al. 1991. The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J. 10:1677-82
12. Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ. 1988. The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335:358-60
13. Mills A, Duggan MJ. 1994. Orphan seven transmembrane domain receptors: reversing pharmacology. Trends Biotechnol. 12:47-49
14. Civelli O, Saito Y, Wang Z, Nothacker HP, Reinscheid RK. 2006. Orphan GPCRs and their ligands. Pharmacol. Ther. 110:525-32
15. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, et al. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-49
16. Marchese A, Docherty JM, Nguyen T, Heiber M, Cheng R, et al. 1994. Cloning of human genes encoding novel G protein-coupled receptors. Genomics 23:609-18
17. O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, et al. 1998. Discovery of three novel Gprotein-coupled receptor genes. Genomics 47:310-13
18. Civelli O. 1998. Functional genomics: the search for novel neurotransmitters and neuropeptides. FEBS Lett. 430:55-58
19. Civelli O, Nothacker HP, Reinscheid R. 1998. Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/nociceptin. Crit. Rev. Neurobiol. 12:163-76
20. Civelli O, Nothacker HP, Saito Y,Wang Z, Lin SH, Reinscheid RK. 2001. Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors. Trends Neurosci. 24:230-37
21. Ozawa A, Lindberg I, Roth B, Kroeze WK. 2010. Deorphanization of novel peptides and their receptors. AAPS J. 12:378-84
22. Liu YF, Civelli O, Zhou QY, Albert PR. 1992. Cholera toxin-sensitive 3-,5-cyclic adenosinemonophosphate and calcium signals of the human dopamine-D1 receptor: selective potentiation by protein kinase A. Mol. Endocrinol. 6(11):1815-24
23. Ferre S, Baler R, Bouvier M, Caron MG, Devi LA, et al. 2009. Building a new conceptual framework for receptor heteromers. Nat. Chem. Biol. 5:131-34
24. Eglen RM, Reisine T. 2009. New insights into GPCR function: implications for HTS. Methods Mol. Biol. 552:1-13
25. Wess G, Urmann M, Sickenberger B. 2001. Medicinal chemistry: challenges and opportunities. Angew. Chem. Int. Ed. 40:3341-50
26. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, et al. 1995. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377:532-35
27. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, et al. 1995. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270:792-94
28. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, et al. 1994. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett. 341:33-38
29. Henderson G, McKnight AT. 1997. The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:293-300
30. Reinscheid RK, Higelin J, Henningsen RA, Monsma FJ Jr, Civelli O. 1998. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J. Biol. Chem. 273:1490-95
31. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-85
32. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, et al. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95:322-27
33. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, et al. 1998. A prolactin-releasing peptide in the brain. Nature 393:272-76
34. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, et al. 1998. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251:471-76
35. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. 1999. Ghrelin is a growthhormone-releasing acylated peptide from stomach. Nature 402:656-60
36. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, et al. 2001. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411:613-17
37. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY. 2002. Identification and molecular characterization of two closely relatedGprotein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J. Biol. Chem. 277:19276-80
38. Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, et al. 2002. Isolation and identification of EGVEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem. Biophys. Res. Commun. 293:396-402
39. Fujii R, Yoshida H, Fukusumi S, Habata Y, Hosoya M, et al. 2002. Identification of a neuropeptide modified with bromine as an endogenous ligand for GPR7. J. Biol. Chem. 277:34010-16
40. Shimomura Y, Harada M, Goto M, Sugo T, Matsumoto Y, et al. 2002. Identification of neuropeptide W as the endogenous ligand for orphan G-protein-coupled receptors GPR7 and GPR8. J. Biol. Chem. 277:35826-32
41. Brezillon S, Lannoy V, Franssen JD, Le Poul E, Dupriez V, et al. 2003. Identification of natural ligands for the orphan G protein-coupled receptors GPR7 and GPR8. J. Biol. Chem. 278:776-83
42. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, et al. 2004. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43:487-97
43. Sato S, Shintani Y, Miyajima N, Yoshimura K. 2002. Novel G protein-coupled receptor protein and DNA thereof. World Patent No. WO 02/345 A1
44. Mori K, Miyazato M, Ida T, Murakami N, Serino R, et al. 2005. Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J. 24:325-35
45. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, et al. 2003. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J. Biol. Chem. 278:7855-62
46. Liu C, Chen J, Sutton S, Roland B, Kuei C, et al. 2003. Identification of relaxin-3/INSL7 as a ligand for GPCR142. J. Biol. Chem. 278:50765-70
47. de Lau W, Barker N, Low TY, Koo BK, Li VSW, et al. 2011. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476:293-97
48. Carmon KS, Gong X, Lin QS, Thomas A, Liu QY. 2011. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulateWnt/β-catenin signaling. Proc. Natl. Acad. Sci. USA 108:11452-7
49. Civelli O. 2008. The orphanin FQ/nociceptin (OFQ/N) system. Results Probl. Cell Differ. 46:1-25
50. Lambert DG. 2008. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat. Rev. Drug Discov. 7:694-710
51. Matsuki T, Sakurai T. 2008. Orexins and orexin receptors: from molecules to integrative physiology. Results Probl. Cell Differ. 46:27-55
52. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. 2001. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24:429-58
53. Lin SH. 2008. Prolactin-releasing peptide. Results Probl. Cell Differ. 46:57-88
54. Kojima M, Kangawa K. 2008. Structure and function of ghrelin. Results Probl. Cell Differ. 46:89-115
55. Colledge WH. 2008. GPR54 and kisspeptins. Results Probl. Cell Differ. 46:117-43
56. Colledge WH. 2009. Kisspeptins and GnRH neuronal signalling. Trends Endocrinol. Metab. 20:115-21
57. Reinscheid RK. 2008. Neuropeptide S: anatomy, pharmacology, genetics and physiological functions. Results Probl. Cell Differ. 46:145-58
58. Zhou QY, Meidan R. 2008. Biological function of prokineticins. Results Probl. Cell Differ. 46:181-99
59. Mori K, Miyazato M, Kangawa K. 2008. Neuromedin S: discovery and functions. Results Probl. Cell Differ. 46:201-12
60. Liu C, Lovenberg TW. 2008. Relaxin-3, INSL5, and their receptors. Results Probl. Cell Differ. 46:213-37
61. Hondo M, Ishii M, Sakurai T. 2008. The NPB/NPW neuropeptide system and its role in regulating energy homeostasis, pain, and emotion. Results Probl. Cell Differ. 46:239-56
62. Kojima M, Kangawa K. 2010. Ghrelin: from gene to physiological function. Results Probl. Cell Differ. 50:185-205
63. Kojima M, Kangawa K. 2010. Ghrelin: more than endogenous growth hormone secretagogue. Ann. N. Y. Acad. Sci. 1200:140-48
64. Lin L, Faraco J, Li R, Kadotani H, Rogers W, et al. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-76
65. Chemelli RM,Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-51
66. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. 2003. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. USA 100:10972-76
67. Coleman PJ, Renger JJ. 2010. Orexin receptor antagonists: a review of promising compounds patented since 2006. Expert Opin. Ther. Pat. 20:307-24
68. Scammell TE,Winrow CJ. 2011. Orexin receptors: pharmacology and therapeutic opportunities. Annu. Rev. Pharmacol. Toxicol. 51:243-66
69. Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freeman K, et al. 2000. A G protein-coupled receptor for UDP-glucose. J. Biol. Chem. 275:10767-71
70. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, et al. 2004. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429:188-93
71. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, et al. 2008. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat. Med. 14:1067-76
72. Goldstein A. 1973. Interactions of narcotic antagonists with receptor sites. Adv. Biochem. Psychopharmacol. 8:471-81
73. Douglass J, Civelli O, Herbert E. 1984. Polyprotein gene expression: generation of diversity of neuroendocrine peptides. Annu. Rev. Biochem. 53:665-715
74. Zylka MJ, Dong X, Southwell AL, Anderson DJ. 2003. Atypical expansion inmice of the sensory neuronspecific Mrg G protein-coupled receptor family. Proc. Natl. Acad. Sci. USA 100:10043-48
75. Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ. 2001. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106:619-32
76. Lembo PM, Grazzini E, Groblewski T, O'Donnell D, Roy MO, et al. 2002. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat. Neurosci. 5:201-9
77. Robas N, Mead E, Fidock M. 2003. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J. Biol. Chem. 278:44400-4
78. Bender E, Buist A, Jurzak M, Langlois X, Baggerman G, et al. 2002. Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule. Proc. Natl. Acad. Sci. USA 99:8573-78
79. Shinohara T, Harada M, Ogi K,Maruyama M, Fujii R, et al. 2004. Identification of a G protein-coupled receptor specifically responsive to β-alanine. J. Biol. Chem. 279:23559-64
80. Han SK, Dong X, Hwang JI, Zylka MJ, Anderson DJ, Simon MI. 2002. Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Gαq/11 pathway. Proc. Natl. Acad. Sci. USA 99:14740-45
81. Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, et al. 2009. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139:1353-65
82. Fredriksson R, Lagerstrom MC, Lundin LG, Schi ̈ oth HB. 2003. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63:1256-72
83. Gloriam DE, Fredriksson R, Schi ̈ oth HB. 2007. The G protein-coupled receptor subset of the rat genome. BMC Genomics 8:338
84. Lagerstrom MC, Schi ̈ othHB. 2008. Structural diversity ofGprotein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7:339-57
85. Bjarnadottir TK, Gloriam DE,Hellstrand SH, Kristiansson H, Fredriksson R, Schi ̈ othHB. 2006. Comprehensive repertoire and phylogenetic analysis of theGprotein-coupled receptors in human andmouse. Genomics 88:263-73
86. Choi JW,Herr DR, Noguchi K, Yung YC, Lee CW, et al. 2010. LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol. 50:157-86
87. Bradshaw HB, Lee SH,McHugh D. 2009. Orphan endogenous lipids and orphan GPCRs: a good match. Prostaglandins Other Lipid Mediat. 89:131-34
88. Yanagida K, Ishii S. 2011. Non-Edg family LPA receptors: the cutting edge of LPA research. J. Biochem. 150:223-32
89. Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, et al. 2006. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl- leukotrienes receptor. EMBO J. 25:4615-27
90. Nordstrom KJ, Lagerstrom MC, Waller LM, Fredriksson R, Schi ̈ oth HB. 2009. The Secretin GPCRs descended from the family of Adhesion GPCRs. Mol. Biol. Evol. 26:71-84
91. Jensen RT, Battey JF, Spindel ER, Benya RV. 2008. International union of pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol. Rev. 60:1-42
92. Mantey SA,Weber HC, Sainz E, Akeson M, Ryan RR, et al. 1997. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J. Biol. Chem. 272:26062-71
93. Ohki-Hamazaki H,Watase K, Yamamoto K, Ogura H, Yamano M, et al. 1997. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390:165-69
94. Zhang S, Yu L. 1995. Identification of dynorphins as endogenous ligands for an opioid receptor-like orphan receptor. J. Biol. Chem. 270:22772-76
95. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, et al. 2005. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996-99
96. Chartrel N, Alvear-Perez R, Leprince J, Iturrioz X, Reaux-Le Goazigo A, et al. 2007. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake." Science 315:766
97. Gourcerol G, St-Pierre DH, Tache Y. 2007. Lack of obestatin effects on food intake: Should obestatin be renamed ghrelin-associated peptide (GAP)? Regul. Pept. 141:1-7
98. Holst B, Egerod KL, Schild E, Vickers SP, Cheetham S, et al. 2007. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148:13-20
99. Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W. 2006. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem. Biophys. Res. Commun. 351:21-25
100. Nogueiras R, Pfluger P, Tovar S, Arnold M, Mitchell S, et al. 2007. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 148:21-26
101. Seoane LM, Al-Massadi O, Pazos Y, Pagotto U, Casanueva FF. 2006. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J. Endocrinol. Investig. 29:RC13-15
102. Zhang JV, Klein C, Ren PG, Kass S, Ver Donck L, et al. 2007. Response to comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake." Science 315:766
103. Zhang JV, Jahr H, Luo CW, Klein C, Van Kolen K, et al. 2008. Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol. Endocrinol. 22:1464-75
104. Yasuda SI, Miyazaki T, Munechika K, Yamashita M, Ikeda Y, Kamizono A. 2007. Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum. J. Recept. Signal Transduct. Res. 27:235-46
105. Duan X, Block E, Li Z, Connelly T, Zhang J, et al. 2012. Crucial role of copper in detection of metalcoordinating odorants. Proc. Natl. Acad. Sci. USA 109:3492-97
106. Rezgaoui M, Susens U, Ignatov A, Gelderblom M, Glassmeier G, et al. 2006. The neuropeptide head activator is a high-affinity ligand for the orphanG-protein-coupled receptor GPR37. J. Cell Sci. 119:542-49
107. Bodenm̈ uller H, Schaller HC. 1981. Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans. Nature 293:579-80
108. Usui M, Aoshima H, Yamamoto Y, Luziga C, Mamba K. 2006. Characterization and distribution of an arginine vasotocin receptor in mouse. J. Vet. Med. Sci. 68:655-61
109. Sugo T, Murakami Y, Shimomura Y, Haradam M, Abe M, et al. 2003. Identification of urotensin IIrelated peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem. Biophys. Res. Commun. 310:860-68
110. Kaupmann K,Huggel K,Heid J, Flor PJ, Bischoff S, et al. 1997. Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors. Nature 386:239-46
111. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, et al. 1998. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-39
112. Levoye A, Dam J, Ayoub MA, Guilllaume JL, Couturier C, et al. 2006. The orphan GPR50 receptor specifically inhibitsMT1 melatonin receptor function through heterodimerization.EMBOJ. 25:3012-23
113. Fridmanis D, FredrikssonR,Kapa I, Schi ̈ oth HB, Klovins J. 2007. Formation of new genes explains lower intron density in mammalian Rhodopsin G protein-coupled receptors. Mol. Phylogenet. Evol. 43:864-80
114. Reitman M, Dishy V, Moreau A, Denney WS, Liu C, et al. 2012. Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients. J. Clin. Pharmacol. 52:1306-16